You Searched For "Big Pharma" and got 20 results
Sort By:
New lawsuits against TikTok mirror those against Big Tobacco and Purdue Pharma
14 state lawsuits filed last week accused TikTok of creating an algorithm that is harmful to childr…
Kenneth Niemeyer
Insider Today: Mark Cuban vs. Big Pharma
In Sunday's edition of Insider Today, we're talking about Mark Cuban's plans to take on Big Pharma,…
Dan DeFrancesco
Mark Cuban is lauding Kamala Harris for joining him in his big fight to lower prescription drug prices
The Harris campaign website said the vice president is committed to bringing down drug prices "by t…
Kwan Wei Kevin Tan
We asked Mark Cuban how he's going to disrupt Big Pharma. He said it's pretty straightforward, actually.
We asked Mark Cuban about his pharmacy, Cost Plus Drugs, and broader vision for US healthcare. He s…
Hilary Brueck
In the competitive world of pharma, companies need to focus on worker well-being to retain top talent, says Ferring's HR exec
Purvi Tailor, Ferring Pharmaceuticals' VP of HR, says focusing holistically on worker well-being is…
Julia Hood
Stock market today: Nifty opens above 25k, metal inches up over 1% in early trade on August 1st, 2024
Maruti, Coal India, Hindalco, JSW Steel and Power Grid Corporation of India were amongst the early …
Stock market today: Nifty, Sensex register muted gains on market opening today
Hindalco, HCL Tech, Mahindra and Mahindra, Coal India, and BPCL took the lead in early trade, while…
Stock Market Today: Maruti, Grasim, and Eicher Motors take lead in early trade
Continuing its momentum from yesterday, Maruti opened the day in green and was up by 1.66%. Grasim,…
Trump once called RFK Jr. a 'Liberal Lunatic.' Now, Kennedy will help plan his 2nd term
Donald Trump and Robert F. Kennedy Jr. once criticized each other. Now, RFK Jr. will help plan a po…
Brent D. Griffiths
Stock market closing: Sensex closes above 80,000, auto, pharma and realty indices rally
Maruti (up by 6.52%), Divis Labs (up by 2.37%), Mahindra and Mahindra (up by 2.23%), Titan (up by 1…
Big Tech is hyping up the power of AI tools. Some of their clients aren't as impressed.
The tech industry's big plans for AI have hit a roadblock: Some of their customers don't find the t…
Dan DeFrancesco
Big Pharma rakes in $215 billion a year in America yet pays almost no taxes
Americans are getting screwed over by Big Pharma twice: first by high drug prices and again by the …
Brad Setser,Tess Turner
Retail traders have been ditching the Magnificent 7 for pharma stocks like Eli Lilly, says JPMorgan
Nividia is still a retail darling, but last week saw individual investors pivot to names like Eli L…
Yuheng Zhan
James Carville says RFK Jr. will harm Trump more than Biden, but he 'worries' about Cornel West and Jill Stein
Robert F. Kennedy Jr. is averaging 12.3% support in national polling in a three-way race with Biden…
John L. Dorman
US generics price pressures ease in Q2, but pharma cos need better product basket
The September quarter saw pharma companies clock double digit revenue growth, even as the sector co…
Krysten Sinema is choosing lower taxes for the richest Americans over better healthcare for average Americans - and cutting the legs out from under the Build Back Better plan
In 2017, Kyrsten Sinema voted against Trump's agenda. Today, she's known as Big Pharma's favorite s…
Laura Packard
Big Pharma is twisting facts to try and convince you that a new plan to lower drug prices would actually be bad. Don't fall for it.
1 in every 3 adults does not take the medications they've been prescribed because they can't afford…
David Mitchell
Insulin prices have tripled over the past decade. Diabetics like me are now being forced to choose between paying for groceries or our medication.
The price of insulin has skyrocketed over the years, and it's killing people who have to choose how…
Melissa McEwen
India's automobile, pharma, tourism sectors expected to grow at rapid pace: PM Modi
Prime Minister Narendra Modi on Monday while addressing the Rozgar Mela where he distributed over 5…
PTI
Concord Biotech lists at 21% premium, beats grey market expectations
Ahmedabad-based pharma company Concord Biotech made its D-street debut at a 21% premium on Friday, …